Modified Citrus Pectin (MCP) Confers a Renoprotective Effect on Early‐Stage Nephropathy in Type‐2 Diabetic Mice
Chemistry & Biodiversity · 2024
DOI: 10.1002/cbdv.202400104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2024. Verfasst von Hager M Mahmoud und 4 weiteren Autor:innen. Beteiligte Einrichtung: Minia General Hospital, 65111, Minia, Egypt. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Pectins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben.
Abstract (Originalsprache)
Diabetic nephropathy (DN) is a significant global health concern with a high morbidity rate. Accumulating evidence reveals that Galectin‐3 (Gal‐3), a β‐galactoside‐binding lectin, is a biomarker in kidney diseases. Our study aimed to assess the advantageous impacts of modified citrus pectin (MCP) as an alternative therapeutic strategy for the initial and ongoing progression of DN in mice with type 2 diabetes mellitus (T2DM). The animal model has been split into four groups: control group, T2DM group (mice received intraperitoneal injections of nicotinamide (NA) and streptozotocin (STZ), T2DM+MCP group (mice received 100 mg/kg/day MCP following T2DM induction), and MCP group (mice received 100 mg/kg/day). After 4 weeks, kidney weight, blood glucose level, serum kidney function tests, histopathological structure alterations, oxidative stress, inflammation, apoptosis, and fibrosis parameters were determined in renal tissues. Our findings demonstrated that MCP treatment reduced blood glucose levels, renal histological damage, and restored kidney weight and kidney function tests. Additionally, MCP reduced malondialdehyde level and restored glutathione level, and catalase activity. MCP demonstrated a notable reduction in inflammatory and apoptosis mediators TNF‐α, iNOS, TGF‐βRII and caspase‐3. Overall, MCP could alleviate renal injury in an experimental model of DN by suppressing renal oxidative stress, inflammation, fibrosis, and apoptosis mediators.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Minia General Hospital, 65111, Minia, Egypt.
- Histology Department, Faculty of Veterinary Medicine, Beni-Suef University, 62511, Beni-Suef, Egypt.
- Biochemistry Department, Faculty of Pharmacy, Deraya University, New Mina, Egypt.
- Biochemistry Department, Faculty of Pharmacy, Minia University, 65111, Minia, Egypt E-mail: amany.
- Cancer Therapy Research Center, Biochemistry Department -I, Biocenter, University of Wuerzburg, Am Hubland, 97074, Würzburg, Germany.
- Bioinformatics Department, Biocenter, University of Wuerzburg, Am Hubland, 97074, Würzburg, Germany.
ORCID-Profile: Eman M Othman
Zitieren
APA
Mahmoud, H. M., Abdel-Razik, A. H., Elrehany, M. A., Othman, E. M., & Bekhit, A. A. (2024). Modified Citrus Pectin (MCP) Confers a Renoprotective Effect on Early‐Stage Nephropathy in Type‐2 Diabetic Mice. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202400104
Vancouver
Mahmoud HM, Abdel-Razik AH, Elrehany MA, Othman EM, Bekhit AA. Modified Citrus Pectin (MCP) Confers a Renoprotective Effect on Early‐Stage Nephropathy in Type‐2 Diabetic Mice. Chemistry & Biodiversity. 2024. doi:10.1002/cbdv.202400104
BibTeX
@article{Mahmoud2024,
author = {Mahmoud, Hager M and Abdel-Razik, Abdel-Razik H and Elrehany, Mahmoud A and Othman, Eman M and Bekhit, Amany A},
title = {Modified Citrus Pectin (MCP) Confers a Renoprotective Effect on Early‐Stage Nephropathy in Type‐2 Diabetic Mice},
journal = {Chemistry & Biodiversity},
year = {2024},
doi = {10.1002/cbdv.202400104}
}
EUVIMED